Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised 3% Hypertonic Saline for Acute Bronchiolitis
NCT06069336Completed
- Sponsor
- Szpital im. Św. Jadwigi Śląskiej
- Start
- Nov 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of hypertonic saline in acute bronchiolitis (2 arms), sponsored by Szpital im. Św. Jadwigi Śląskiej. Primary endpoint: Length of hospital stay. Started Nov 2023; status: completed.
02
Drugs
hypertonic saline
03
Conditions
acute bronchiolitis
Beyond the preview
Go deeper on NCT06069336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06069336.